CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
Frequently asked questions
What sector does Cannlabs Inc (CANL) operate in?
Cannlabs Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Cannlabs Inc (CANL) current stock price?
As of the latest data, Cannlabs Inc stock price is $0.00, with a previous close of $0.00.
What is Cannlabs Inc (CANL) current market capitalization?
Cannlabs Inc market cap is approximately 46.32 thousand.
Does Cannlabs Inc (CANL) pay dividends?
No. Cannlabs Inc does not pay a dividend.
What is Cannlabs Inc (CANL) beta (volatility) score?
Cannlabs Inc has a beta of 295.514, indicating very high volatility compared to the market.